口腔生物医学 ›› 2020, Vol. 11 ›› Issue (4): 207-213.
• 述评 • 下一篇
陆跃智,张文杰,蒋欣泉*
收稿日期:
2020-11-11
修回日期:
2020-12-02
出版日期:
2020-12-25
发布日期:
2021-01-13
通讯作者:
蒋欣泉
E-mail:xinquanj@aliyun.com
基金资助:
国家重点研发计划(2016YFC1102900);国家自然科学基金(81921002,81620108006)
Received:
2020-11-11
Revised:
2020-12-02
Online:
2020-12-25
Published:
2021-01-13
摘要: 因肿瘤切除、外伤、炎症以及先天性疾病等原因造成的口腔颌面部骨缺损会造成口腔功能障碍,影响患者的身心健康和生活质量。骨形态发生蛋白2(BMP-2)是重要的成骨调控因子,具有最强的成骨诱导能力,是骨组织工程中应用最广泛的生长因子之一。本文对BMP-2的成骨剂量与不良反应、递送系统以及在口腔颌面部骨再生中的临床应用进行综述。
陆跃智 张文杰 蒋欣泉. BMP-2与口腔颌面部骨再生[J]. 口腔生物医学, 2020, 11(4): 207-213.
[1] | Urist MR.Bone: formation by autoinduction[J].Science, 1965, 150(3698):893-899 |
[2] | Urist MR, Strates BS.Bone morphogenetic protein[J].J Dent Res, 1971, 50(6):1392-1406 |
[3] | Kessler E, Takahara K, Biniaminov L, et al.Bone morphogenetic protein-1: the type I procollagen C-proteinase[J].Science, 1996, 271(5247):360-362 |
[4] | El Bialy I, Jiskoot W, Reza Nejadnik M.Formulation,delivery and stability of bone morphogenetic proteins for effective bone regeneration[J].Pharm Res, 2017, 34(6):1152-1170 |
[5] | Viljanen VV, Gao TJ, Marttinen A, et al.Partial purification and characterization of bone morphogenetic protein from bone matrix of the premature moose (Alces alces): Degradation of bone-inducing activity during storage[J].Eur Surg Res, 1996, 28(6):447-460 |
[6] | Wozney J, Rosen V, Celeste A, et al.Novel regulators of bone formation: Molecular clones and activities[J].Science, 1988, 242(4885):1528-1534 |
[7] | Burkus JK, Transfeldt EE, Kitchel SH, et al.Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2[J].Spine, 2002, 27(21):2396-2408 |
[8] | Burkus JK, Gornet MF, Dickman CA, et al.Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages[J].J Spinal Disord Tech, 2002, 15(5):337-349 |
[9] | James AW, LaChaud G, Shen J, et al.A review of the clinical side effects of bone morphogenetic protein-2[J].Tissue Eng Part B: Rev, 2016, 22(4):284-297 |
[10] | Schmidt-Bleek K, Willie BM, Schwabe P, et al.BMPs in bone regeneration: Less is more effective,a paradigm-shift[J].Cytokine Growth Factor Rev, 2016, 27:141-148 |
[11] | Boden SD, Kang J, Sandhu H, et al.Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: A prospective,randomized clinical pilot trial: 2002 Volvo Award in clinical studies[J].Spine, 2002, 27(23):2662-2673 |
[12] | Boden SD, Martin GJ Jr, Horton WC, et al.Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage[J].J Spinal Disord, 1998, 11(2):95-101 |
[13] | Boden SD, Martin GJ, Morone MA, et al.Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate[J].Spine, 1999, 24(12):1179-1185 |
[14] | Govender S, Csimma C, Genant HK, et al.Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures[J].J Bone Joint Surg Am, 2002, 84(12):2123-2134 |
[15] | Fiorellini JP, Howell TH, Cochran D, et al.Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation[J].J Periodontol, 2005, 76(4):605-613 |
[16] | Boyne PJ, Lilly LC, Marx RE, et al.De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation[J].J Oral Maxillofac Surg, 2005, 63(12):1693-1707 |
[17] | Carragee EJ, Hurwitz EL, Weiner BK.A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned[J].Spine J, 2011, 11(6):471-491 |
[18] | Itoh K, Udagawa N, Katagiri T, et al.Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand[J].Endocrinology, 2001, 142(8):3656-3662 |
[19] | Granholm S, Henning P, Lindholm C, et al.Osteoclast progenitor cells present in significant amounts in mouse calvarial osteoblast isolations and osteoclastogenesis increased by BMP-2[J].Bone, 2013, 52(1):83-92 |
[20] | Tachi K, Takami M, Zhao BH, et al.Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts[J].Cell Tissue Res, 2010, 342(2):213-220 |
[21] | Huntley R, Jensen E, Gopalakrishnan R, et al.Bone morphogenetic proteins: Their role in regulating osteoclast differentiation[J].Bone Rep, 2019, 10:100207- |
[22] | Zara JN, Siu RK, Zhang XL, et al.High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo[J].Tissue Eng Part A, 2011, 17(910):1389-1399 |
[23] | Lee KB, Taghavi CE, Song KJ, et al.Inflammatory characteristics of rhBMP-2 in vitro and in an in vivo rodent model[J].Spine, 2011, 36(3):E149-E154 |
[24] | Nguyen V, Meyers CA, Yan N, et al.BMP-2-induced bone formation and neural inflammation[J].J Orthop, 2017, 14(2):252-256 |
[25] | Haidar ZS, Hamdy RC, Tabrizian M.Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering[J].Biotechnol Lett, 2009, 31(12):1825-1835 |
[26] | Lo KWH, Ulery BD, Ashe KM, et al.Studies of bone morphogenetic protein-based surgical repair[J].Adv Drug Deliv Rev, 2012, 64(12):1277-1291 |
[27] | Haidar ZS, Hamdy RC, Tabrizian M.Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering[J].Biotechnol Lett, 2009, 31(12):1825-1835 |
[28] | Welch RD, Jones AL, Bucholz RW, et al.Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model[J].J Bone Miner Res, 1998, 13(9):1483-1490 |
[29] | Bouxsein ML, Turek TJ, Blake CA, et al.Recombinant human bone morphogenetic protein-2 accelerates healing in a rabbit ulnar osteotomy model[J].J Bone Joint Surg Am, 2001, 83(8):1219-1230 |
[30] | Boyne PJ.Animal studies of application of rhBMP-2 in maxillofacial reconstruction[J].Bone, 1996, 19(1 Suppl):83S-92S |
[31] | Lee KW, Lee JS, Jang JW, et al.Tendon-bone interface healing using an injectable rhBMP-2-containing collagen gel in a rabbit extra-articular bone tunnel model[J].J Tissue Eng Regen Med, 2017, 11(5):1435-1441 |
[32] | Geiger M.Collagen sponges for bone regeneration with rhBMP-2[J].Adv Drug Deliv Rev, 2003, 55(12):1613-1629 |
[33] | Li RH, Wozney JM.Delivering on the promise of bone morphogenetic proteins[J].Trends Biotechnol, 2001, 19(7):255-265 |
[34] | Ijiri S, Yamamuro T, Nakamura T, et al.Effect of sterilization on bone morphogenetic protein[J].J Orthop Res, 1994, 12(5):628-636 |
[35] | Pekkarinen T, Hietalal O, J?ms? T, et al.Gamma irradiation and ethylene oxide in the sterilization of native reindeer bone morphogenetic protein extract[J].Scand J Surg, 2005, 94(1):67-70 |
[36] | Pekkarinen T, Hietala O, Lindholm TS, et al.Influence of ethylene oxide sterilization on the activity of native reindeer bone morphogenetic protein[J].Int Orthop, 2004, 28(2):97-101 |
[37] | Yamamoto M, Takahashi Y, Tabata Y.Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel[J].Tissue Eng, 2006, 12(5):1305-1311 |
[38] | Patel ZS, Yamamoto M, Ueda H, et al.Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2[J].Acta Biomater, 2008, 4(5):1126-1138 |
[39] | Wang HN, Boerman OC, Sariibrahimoglu K, et al.Comparison of micro- vs. nanostructured colloidal gelatin gels for sustained delivery of osteogenic proteins: Bone morphogenetic protein-2 and alkaline phosphatase[J].Biomaterials, 2012, 33(33):8695-8703 |
[40] | Zhang WJ, Zhu C, Ye DX, et al.Porous silk scaffolds for delivery of growth factors and stem cells to enhance bone regeneration[J].PLoS One, 2014, 9(7):e102371- |
[41] | Zhang WJ, Wang XL, Wang SY, et al.The use of injectable sonication-induced silk hydrogel for VEGF(165) and BMP-2 delivery for elevation of the maxillary sinus floor[J].Biomaterials, 2011, 32(35):9415-9424 |
[42] | Hunt DR, Jovanovic SA, Wikesj? UM, et al.Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A pilot study[J].J Periodontol, 2001, 72(5):651-658 |
[43] | Kim J, Kim IS, Cho TH, et al.Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells[J].Biomaterials, 2007, 28(10):1830-1837 |
[44] | Fu TS, Chen WJ, Chen LH, et al.Enhancement of posterolateral lumbar spine fusion using low-dose rhBMP-2 and cultured marrow stromal cells[J].J Orthop Res, 2009, 27(3):380-384 |
[45] | Abarrategi A, Civantos A, Ramos V, et al.Chitosan film as rhBMP2 carrier: Delivery properties for bone tissue application[J].Biomacromolecules, 2008, 9(2):711-718 |
[46] | Schliephake H, Weich HA, Dullin C, et al.Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid: An experimental study in rats[J].Biomaterials, 2008, 29(1):103-110 |
[47] | Facca S, Ferrand A, Mendoza-Palomares C, et al.Bone formation induced by growth factors embedded into the nanostructured particles[J].J Biomed Nanotechnol, 2011, 7(3):482-485 |
[48] | Hernández A, Reyes R, Sánchez E, et al.In vivo osteogenic response to different ratios of BMP-2 and VEGF released from a biodegradable porous system[J].J Biomed Mater Res A, 2012, 100(9):2382-2391 |
[49] | Cao LY, Kong XJ, Lin SX, et al.Synergistic effects of dual growth factor delivery from composite hydrogels incorporating 2-N,6-O-sulphated chitosan on bone regeneration[J].Artif Cells Nanomed Biotechnol, 2018, 46(sup3):S1-S17 |
[50] | Chang PC, Liu BY, Liu CM, et al.Bone tissue engineering with novel rhBMP2-PLLA composite scaffolds[J].J Biomed Mater Res A, 2007, 81(4):771-780 |
[51] | Barati D, Shariati SRP, Moeinzadeh S, et al.Spatiotemporal release of BMP-2 and VEGF enhances osteogenic and vasculogenic differentiation of human mesenchymal stem cells and endothelial colony-forming cells co-encapsulated in a patterned hydrogel[J].J Control Release, 2016, 223:126-136 |
[52] | Miszuk JM, Xu T, Yao Q, et al.Functionalization of PCL-3D electrospun nanofibrous scaffolds for improved BMP2-induced bone formation[J].Appl Mater Today, 2018, 10:194-202 |
[53] | Agrawal V, Sinha M.A review on carrier systems for bone morphogenetic protein-2[J].J Biomed Mater Res, 2017, 105(4):904-925 |
[54] | Lee EU, Lim HC, Hong JY, et al.Bone regenerative efficacy of biphasic calcium phosphate collagen composite as a carrier of rhBMP-2[J].Clin Oral Impl Res, 2016, 27(11):e91-e99 |
[55] | Zhao J, Shen G, Liu CS, et al.Enhanced healing of rat calvarial defects with sulfated chitosan-coated calcium-deficient hydroxyapatite/bone morphogenetic protein 2 scaffolds[J].Tissue Eng Part A, 2012, 18(1/2):185-197 |
[56] | Zhu SS, Song DH, Jiang XW, et al.Combined effects of recombinant human BMP-2 and Nell-1 on bone regeneration in rapid distraction osteogenesis of rabbit Tibia[J].Injury, 2011, 42(12):1467-1473 |
[57] | Shah NJ, Hyder MN, Quadir MA, et al.Adaptive growth factor delivery from a polyelectrolyte coating promotes synergistic bone tissue repair and reconstruction[J].Proc Natl Acad Sci U S A, 2014, 111(35):12847-12852 |
[58] | Jo JY, Jeong SI, Shin YM, et al.Sequential delivery of BMP-2 and BMP-7 for bone regeneration using a heparinized collagen membrane[J].Int J Oral Maxillofac Surg, 2015, 44(7):921-928 |
[59] | Kim S, Lee S, Kim K.Bone Tissue Engineering Strategies in Co-Delivery of Bone Morphogenetic Protein-2 and Biochemical Signaling Factors[J].Adv Exp Med Biol, 2018, 1078:233-244 |
[60] | Park SY, Kim KH, Kim S, et al.BMP-2 gene delivery-based bone regeneration in dentistry[J].Pharmaceutics, 2019, 11(8):393- |
[61] | Jiang XQ, Zhao J, Wang SY, et al.Mandibular repair in rats with premineralized silk scaffolds and BMP-2-modified bMSCs[J].Biomaterials, 2009, 30(27):4522-4532 |
[62] | Xia LG, Xu YJ, Chang Q, et al.Maxillary sinus floor elevation using BMP-2 and nell-1 gene-modified bone marrow stromal cells and TCP in rabbits[J].Calcif Tissue Int, 2011, 89(1):53-64 |
[63] | Zhu Y, Li DW, Zhang K, et al.Novel synthesized nanofibrous scaffold efficiently delivered hBMP-2 encoded in adenoviral vector to promote bone regeneration[J].J Biomed Nanotechnol, 2017, 13(4):437-446 |
[64] | Kawai M, Kataoka YH, Sonobe J, et al.Non-surgical model for alveolar bone regeneration by bone morphogenetic protein-2/7 gene therapy[J].J Periodontol, 2018, 89(1):85-92 |
[65] | Kim HJ, Chung JH, Shin SY, et al.Efficacy of rhBMP-2/Hydroxyapatite on Sinus Floor Augmentation: A Multicenter, Randomized Controlled Clinical Trial[J].J Dent Res, 2015, 94(9 Suppl):158S-165S |
[66] | Kim MS, Lee JS, Shin HK, et al.Prospective randomized, controlled trial of sinus grafting using Escherichia-coli-produced rhBMP-2 with a biphasic calcium phosphate carrier compared to deproteinized bovine bone[J].Clin Oral Impl Res, 2015, 26(12):1361-1368 |
[67] | Kao DW, Kubota A, Nevins M, et al.The negative effect of combining rhBMP-2 and Bio-Oss on bone formation for maxillary sinus augmentation[J].Int J Periodontics Restorative Dent, 2012, 32(1):61-67 |
[68] | Coomes AM, Mealey BL, Huynh-Ba G, et al.Buccal bone formation after flapless extraction: a randomized, controlled clinical trial comparing recombinant human bone morphogenetic protein 2/absorbable collagen carrier and collagen sponge alone[J].J Periodontol, 2014, 85(4):525-535 |
[69] | de Freitas RM, Susin C, Spin-Neto R, et al.Horizontal ridge augmentation of the atrophic anterior maxilla using rhBMP-2/ACS or autogenous bone grafts: a proof-of-concept randomized clinical trial[J].J Clin Periodontol, 2013, 40(10):968-975 |
[70] | Nam JW, Khureltogtokh S, Choi HM, et al.Randomised controlled clinical trial of augmentation of the alveolar ridge using recombinant human bone morphogenetic protein 2 with hydroxyapatite and bovine-derived xenografts: Comparison of changes in volume[J].Br J Oral Maxillofac Surg, 2017, 55(8):822-829 |
[71] | Dickinson BP, Ashley RK, Wasson KL, et al.Reduced morbidity and improved healing with bone morphogenic protein-2 in older patients with alveolar cleft defects[J].Plast Reconstr Surg, 2008, 121(1):209-217 |
[72] | Alonso N, Tanikawa DY, Freitas Rda S, et al.Evaluation of maxillary alveolar reconstruction using a resorbable collagen sponge with recombinant human bone morphogenetic protein-2 in cleft lip and palate patients[J].Tissue Eng Part C Methods, 2010, 16(5):1183-1189 |
[73] | Canan LW Jr, da Silva Freitas R, Alonso N, et al.Human bone morphogenetic protein-2 use for maxillary reconstruction in cleft lip and palate patients[J].J Craniofacial Surg, 2012, 23(6):1627-1633 |
[74] | Kim MS, Kim KJ, Kim BJ, et al.Immediate reconstruction of mandibular defect after treatment of medication-related osteonecrosis of the jaw (MRONJ) with rhBMP-2/ACS and miniplate: Review of 3 cases[J].Int J Surg Case Rep, 2020, 66:25-29 |
[75] | Oliveira MR, Gorla LF, Gabrielli MA, et al.Off-label use of bone morphogenetic protein 2 in the reconstructions of mandibular continuity defects[J].J Craniofacial Surg, 2017, 28(1):227-230 |
[76] | Cicciù M, Herford AS, Cicciù D, et al.Recombinant human bone morphogenetic protein-2 promote and stabilize hard and soft tissue healing for large mandibular new bone reconstruction defects[J].J Craniofacial Surg, 2014, 25(3):860-862 |
[77] | Balaji SM.Protein-signaled guided total jaw regeneration in infantile total mandibular resection[J].Ann Maxillofac Surg, 2014, 4(2):198- |
[1] | 王轲 赵兵杰 陈云. 慢性睡眠剥夺对大鼠颞下颌关节的影响[J]. , 2020, 11(4): 246-251. |
[2] | 曾柏瑞 吴佳颖 闫一诺 洪筠. VEGF - C与口腔鳞状细胞癌淋巴管生成的研究进展[J]. , 2019, 10(4): 218-221. |
[3] | 祝祥清 周侨 陈杨 徐艳 孙颖. 内毒素耐受对THP-1细胞分泌ENA-78和EGF的影响[J]. , 2016, 7(1): 30-33. |
[4] | 李向东 朱思超 杨锋 常菊花 马培亚. 平阳霉素瘤内注射对婴幼儿血管瘤血清中血管内皮生长因子表达的影响[J]. , 2013, 4(3): 138-141. |
[5] | 王林红 郑园娜. 全反式维甲酸与骨形态发生蛋白的联合成骨作用研究进展[J]. , 2012, 3(4): 208-211. |
[6] | 程楠, 徐燕. 富血小板纤维在口腔医学的研究进展[J]. , 2012, 3(1): 37-41. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||